Unlocking grip strength for application in data-driven healthcare.

Cardiovascular risk

The Lancet PURE study (2015) followed 139,691 adults across 17 countries and found that each 5 kg reduction in grip strength was associated with a 17% increase in cardiovascular mortality. Per 3.5 kg of decline, all-cause mortality risk rose by 16%. Grip strength outperformed systolic blood pressure as a predictor of death from any cause.

Cancer risk

Lower grip strength is associated with increased cancer mortality. A UK Biobank prospective study (2018) of >500k participants, showed that each 5 kg decrement in grip strength was associated with a roughly 17% higher risk of cancer death in women and a 10% higher risk in men. These associations persisted after adjustment for age, ethnicity, deprivation, BMI, smoking, physical activity, and comorbidities.

Frailty and falls

Grip strength is one of the five Fried frailty criteria and a core component of sarcopenia diagnosis under the EWGSOP2 definition. Low grip strength is independently associated with increased falls risk, reduced mobility and loss of independence in older adults.

Population health applications

At scale, grip strength data enables population-level risk stratification. Public health teams can identify cohorts at elevated risk of functional decline, target preventive interventions and track the effectiveness of programs over time. Standardized digital capture makes this feasible across distributed care settings.